Results 61 to 70 of about 1,537,624 (159)

A CASE OF MALIGNANT PHYLLODES TUMOR

The journal of the Japanese Practical Surgeon Society, 1994
Phyllodes tumors are fibroepithelial tumors which peculiar to the breast. Among of them, mamlignant phyllodes tumors are rare. This paper presents a case of malignant phyllodes tumor with a 30-year ailing period, together with a review of the literature.
MASAKI, Yuji, SASAKI, Joji, SEYAMA, Atsushi, YAMAMOTO, Tatsuhito, HASEGAWA, Hiroyasu, MIYASHITA, Hiroshi, TATEBAYASHI, Kinichiro   +6 more
openaire   +2 more sources

Giant malignant phyllodes tumor with metastasis to the brain [PDF]

Baylor University Medical Center Proceedings, 2019
We present the case of a 32-year-old African American woman with a giant malignant phyllodes tumor that metastasized to the lungs and subsequently the brain. Her treatment included six cycles of adjuvant therapy with AIM (Adriamycin®, ifosfamide, and mesna) followed by therapy with gemcitabine and docetaxel. A grand mal seizure led to discovery of a 6 ×
Alden P. Gregston, David M. Metter, Cynthia R. C. Osborne, John Pippen   +3 more
openaire   +2 more sources

Malignant phyllodes tumor of the breast: a systematic review

Pathologica, 2022
Phyllodes tumors (PT) are fibroepithelial neoplasms of the breast showing a peculiar leaf-like appearance. They account for 0.3 to 1% of all primary breast tumors and 2.5% of all fibroepithelial breast tumors. PT are classified into benign, borderline and malignant based upon their stromal morphology with a distribution of 60%, 20%, and 20 ...
Lissidini, Germana, Mulè, Antonino, Santoro, Angela, Papa, Giovanni, Nicosia, Luca, Cassano, Enrico, Ashoor, Arwa Ahmed, Veronesi, Paolo, Pantanowitz, Liron, Hornick, Jason L, Rossi, Esther Diana   +10 more
openaire   +3 more sources

Giant malignant phyllodes tumor of the breast: Insights into optimal management and reconstructive options for a rare and challenging entity

, 2020
Giant malignant phyllodes tumor of the breast: Insights into optimal management and reconstructive options for a rare and challenging ...
Gottardi, Alessandra, Galimberti V., Crown, Angelena, Toesca, Antonio, Ashoor, Arwa Ahmed, Ashoor A. A., Pizzamiglio M., Farante, Gabriel, Lissidini G., Pizzamiglio, Maria, Rossi, Diana Esther, Trifirò, Giuseppe, Pennacchioli E., Crown A., Gottardi A., Papa G., Girardi A., Toesca A., Galimberti, Viviana, Rossi D. E., Veronesi P., Girardi, Antonia, Trifiro G., Pennacchioli, Elisabetta, Lissidini, Germana, Farante G., Veronesi, Paolo, Papa, Giovanni   +27 more
core   +1 more source

Integration of Raman Spectroscopy and Metabolomics for Early Breast Cancer Detection and Classification

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Breast cancer, now the fourth leading cause of cancer‐related mortality worldwide, necessitates early detection for improved clinical outcomes. Conventional histopathology, though widely used, is invasive and subjective, limiting its utility in early‐stage diagnosis.
Xue Li, He Ren, Yuhan Deng, Yang Li, Fangjie Hu   +4 more
wiley   +1 more source

Recurrent malignant phyllodes tumor of the breast

Medicine, 2017
Phyllodes tumor is a rare fibro epithelial neoplasm of the breast. They resemble fibroadenomas clinically and can be mistakenly ignored sometimes.We report the case of a young woman with her first presentation to hospital due to a hypoglycemia and she underwent 2 excised fibroadenomas in the same breast before diagnosed of malignant phyllodes tumor ...
Wang, Qinqin, Su, Jing, Lei, Yutao
openaire   +2 more sources

Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Concomitant medications (CMs) influence outcomes in patients receiving immune checkpoint inhibitors (ICIs), but their impact in sarcoma remains undefined. We assessed the association between CM use and ICI outcomes in patients with advanced or metastatic sarcoma. Methods This pooled analysis included patients from seven investigator‐
Adel Shahnam, Kristen DiConza, Simran Jasnani, Rhoena Desir‐Camille, Evan Rosenbaum, Olayode Babatunde, Ciara M. Kelly, Lauren B. Banks, Viswatej Avutu, Ping Chi, Sujana Movva, Mark A. Dickson, Mrinal M. Gounder, Mary L. Keohan, Robert G. Maki, William D. Tap, Sandra P. D'Angelo   +16 more
wiley   +1 more source

EKSPRESI CD117 DAN Ki-67 PADA TUMOR PHYLLODES BENIGN, BORDERLINE DAN MALIGNANT [PDF]

, 2016
Backgroud: Phyllodes tumors are uncommon stromal-epithelial neoplasms, and classified into benign, borderline, and malignant groups on the basis of their histological features. Until now pathogenesis of phyllodes tumor is unclear.
Fetty Fatimah, NIM011181408
core   +1 more source

Beyond the Triple‐Negative Label: A Case Report on Metaplastic Breast Carcinoma

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Metaplastic breast carcinoma (MpBC) is a rare, aggressive breast malignancy with poorer prognosis than conventional subtypes. Predominant hematogenous spread, frequent triple‐negative phenotype, chemoresistance, rarity, and poorly defined treatment protocols render MpBC a significant diagnostic and therapeutic challenge for oncologists in ...
Samana Oli, Ayush Sapkota, Sajjad Ahmed Khan, Asmita Rayamajhi, Dhiraj Gupta, Vivek Ghosh, Diksha Karki, Rikesh Acharya, Prajina Shrestha   +8 more
wiley   +1 more source

Prostatic stromal tumors with uncertain malignant potential: A scoping review of clinical challenges and management strategies

UroPrecision, Volume 4, Issue 2, Page 88-97, June 2026.
Abstract Prostatic stromal tumor of uncertain malignant potential (STUMP) is a rare neoplasm arising from specialized prostatic stromal cells with a broad range of histologic patterns and unpredictable clinical behavior. It is often challenging to distinguish STUMP from prostatic stromal sarcoma due to morphological similarities, necessitating specific
Ibrahim A. Khalil, Abdullah M. Al‐Jubouri, Khaled Murshed, Ahmad R. Al‐Qudimat, Majd Alkabbani, Nagy Younes, Khalid Al Jalham, Khalid Al Rumaihi   +7 more
wiley   +1 more source